← All stories
Markets
enGene to Participate in Upcoming Investor Conferences
BOSTON & MONTREAL — enGene Therapeutics Inc. (Nasdaq: ENGN, “enGene” or the “Company”), a clinical-stage, non-viral genetic medicines company today announced that management will participate in the following investor conferences: Wells Farg…
Covered by 1 outlet
All coverage · 1 article